Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 11, 2025 • 3:30 AM ET

Date/Time Source News Release
07/10/2025 08:30 AM EDT ACCESS Newswire Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
06/30/2025 09:00 AM EDT ACCESS Newswire Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
06/26/2025 09:00 AM EDT ACCESS Newswire Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset
06/25/2025 09:00 AM EDT ACCESS Newswire Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs
06/24/2025 04:15 PM EDT ACCESS Newswire Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026
06/23/2025 09:00 AM EDT ACCESS Newswire Jaguar Health Provides Updates on Orphan Disease Intestinal Failure Development Program for Crofelemer
06/17/2025 09:00 AM EDT ACCESS Newswire Jaguar Health Presenting June 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts
06/17/2025 07:00 AM EDT GlobeNewswire Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream
06/11/2025 10:00 AM EDT ACCESS Newswire First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
06/09/2025 04:15 PM EDT ACCESS Newswire REMINDER: Jaguar Health to Conduct Fireside Chat 9AM ET June 10 as Part of Lytham Partners' Spring 2025 Spotlight Series
Page

Additional News

As of July 11, 2025 • 3:30 AM ET

Date/Time Source News Release
06/20/2025 04:43 PM EDT SeekingAlpha Jaguar Health files to sell 507.4K shares of common stock by selling shareholders
05/21/2025 08:12 AM EDT SeekingAlpha Jaguar Health prices 0.25M shares at $6.09 in registered direct offering
05/15/2025 08:45 PM EDT SeekingAlpha Jaguar Health outlines rare disease catalyst convergence and expedited regulatory pathways for crofelemer following proof-of-concept results
05/15/2025 08:43 PM EDT SeekingAlpha Jaguar Health, Inc. (JAGX) Q1 2025 Earnings Call Transcript
05/15/2025 04:01 PM EDT SeekingAlpha Jaguar Health GAAP EPS of -$16.70, revenue of $2.21M
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Jaguar Health Inc.
04/25/2025 11:37 AM EDT InvestorBrandNetwork Jaguar Health Inc. (NASDAQ: JAGX) Rises Sharply in 4/25 Early Trading Session
04/15/2025 04:43 PM EDT SeekingAlpha Jaguar Health files to sell 1.29M shares of common stock for holders
04/06/2025 06:49 PM EDT KlickAnalytics JAGX - Historical Price Movements Surrounding Earnings
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.